I3Y-MC-JPBM aromatase inhibitor ± CDK 4/6 inhibotor stage IV BC

The main purpose of this study is to evaluate how effective nonsteroidal aromatase inhibitors (NSAI) plus abemaciclib are in postmenopausal women with breast cancer.

September 25, 2015